Abstract
We describe a case of Linezolid-induced severe toxic optic neuropathy in a patient with drug-resistant tuberculosis. Linezolid produced severe toxic optic neuropathy in some who used it for a long time. To the best of our knowledge, the optic neuropathy was completely reversed after omitting Linezolid which is one of the effective drug regimens in his prescription, with significant improvements in eye vision.
Highlights
Toxic optic neuropathy has been reported as an uncommon side effect of Linezolid treatment for a longer duration with the majority of cases
[1] Staphylococcus aureus bacteria are the most common pathogen isolated in all types and stages of Osteomyelitis, and these strains are not treated by Methicillin a day
[5] We present a case of reversible optic neuropathy in a patient with XDR-TB who experienced it after long-term treatment (TB)
Summary
Occurring in adults. [1,2,3,4,5] various cases have been documented in people of varying ages. Linezolid treatment for extensively drug-resistant tuberculosis (XDR-TB). [1] Staphylococcus aureus bacteria are the most common pathogen isolated in all types and stages of Osteomyelitis, and these strains are not treated by Methicillin a day. MRSAinduced Osteomyelitis is managed with Linezolid, which is active on most MRSA strains. [2] It has been successfully utilized as a long-term treatment for persistent Staphylococcus aureus Osteomyelitis despite its less than ideal safety profile. [3,4,5] the reported neuropathy resulted in blindness with one case found. [5] We present a case of reversible optic neuropathy in a patient with XDR-TB who experienced it after long-term treatment (TB). The reversibility of optic nerve involvement has been proven in the visual examination after treatment has ended
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
